Up a level |
Number of items: 1.
Castle, John, Blower, Emma, Bundred, Nigel J, Harvey, James R, Thachil, Jecko, Marshall, Andrea, Cox, Karina, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Holcombe, Chris, Palmieri, Carlos ORCID: 0000-0001-9496-2718 et al (show 1 more authors)
(2020)
Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial.
TRIALS, 21 (1).
749-.